Skip to main content
Erschienen in: Rheumatology International 8/2014

01.08.2014 | Short Communication

Vitamin D in “early” primary Sjögren’s syndrome: does it play a role in influencing disease phenotypes?

verfasst von: Chiara Baldini, Andrea Delle Sedie, Nicoletta Luciano, Pasquale Pepe, Francesco Ferro, Rosaria Talarico, Chiara Tani, Marta Mosca

Erschienen in: Rheumatology International | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Beyond its well-established role in the maintenance of mineral homeostasis, 25-OH-vitamin D deficiency seems to be involved in the development and severity of several autoimmune diseases. To date, contrasting data have been reported regarding the presence of hypovitaminosis D in primary Sjögren’s syndrome (pSS). To assess the prevalence of hypovitaminosis D in pSS at an early stage of the disease and to evaluate its impact on pSS clinical manifestations and disease activity, unselected consecutive subjects with recent onset dry mouth and/or dry eyes who underwent a comprehensive diagnostic algorithm for pSS (AECG criteria) were prospectively included in the study. The levels of 25[OH]-D3 were measured by monoclonal antibody immunoradiometric assay. Conditions of 25[OH]-D3 severe deficiency, deficiency, and insufficiency were defined as levels <10, <20, and 20–30 ng/ml, respectively, and their frequencies were investigated in pSS patients and controls. The levels of 25[OH]-D3 were also correlated with patients’ demographic, clinical, and serologic features. Seventy-six consecutive females were included: 30/76 patients fulfilled the AECG criteria for pSS. The remaining 46/76 patients represented the control group. No statistical differences were found in the serum levels of 25[OH]-D3 between pSS patients [median levels = 20 ng/ml (IQR 9.3–26)] and controls [median levels = 22.5 ng/ml (IQR 15.6–33)]. In particular, the frequency of 25[OH]-D3 severe deficiency was not significantly different in patients with pSS when compared to controls (23 vs. 17.4 %, p value = 0.24). We found a significant correlation between serum 25[OH]-D3 levels and white blood cells count (r = 0.29, p = 0.01). More specifically, leukocytopenia was significantly associated with 25[OH]-D3 severe deficiency, being documented in 40 % of the subjects with a 25[OH]-D3 severe deficiency and in 11 % of the subjects without a severe vitamin D deficiency (p = 0.02). We did not observe any further association or correlation between hypovitaminosis D and pSS glandular and extra-glandular features. Although the role of hypovitaminosis D in pSS pathogenesis remains controversial, the results of this study encourage the assessment of vitamin D in specific pSS subsets that could mostly benefit from a supplementation.
Literatur
1.
Zurück zum Zitat Cutolo M, Plebani M, Shoenfeld Y, Adorini L, Tincani A (2011) Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm 86:327–351PubMedCrossRef Cutolo M, Plebani M, Shoenfeld Y, Adorini L, Tincani A (2011) Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm 86:327–351PubMedCrossRef
2.
Zurück zum Zitat Vacca A, Cormier C, Mathieu A, Kahan A, Allanore Y (2011) Vitamin D levels and potential impact in systemic sclerosis. Clin Exp Rheumatol 29(6):1024–1031PubMed Vacca A, Cormier C, Mathieu A, Kahan A, Allanore Y (2011) Vitamin D levels and potential impact in systemic sclerosis. Clin Exp Rheumatol 29(6):1024–1031PubMed
3.
Zurück zum Zitat Di Munno O, Mazzantini M, Delle Sedie A, Mosca M, Bombardieri S (2004) Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus 13(9):724–730PubMedCrossRef Di Munno O, Mazzantini M, Delle Sedie A, Mosca M, Bombardieri S (2004) Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus 13(9):724–730PubMedCrossRef
4.
Zurück zum Zitat Hélou J, Moutran R, Maatouk I, Haddad F (2013) Raynaud’s phenomenon and vitamin D. Rheumatol Int 33(3):751–755 Hélou J, Moutran R, Maatouk I, Haddad F (2013) Raynaud’s phenomenon and vitamin D. Rheumatol Int 33(3):751–755
5.
Zurück zum Zitat Muller K, Oxholm P, Sorensen OH, Thymann M, Hoier-Madsen M, Bendtzen K (1990) Abnormal vitamin D3 metabolism in patients with primary Sjogren’s syndrome. Ann Rheum Dis 49(9):682–684PubMedCentralPubMedCrossRef Muller K, Oxholm P, Sorensen OH, Thymann M, Hoier-Madsen M, Bendtzen K (1990) Abnormal vitamin D3 metabolism in patients with primary Sjogren’s syndrome. Ann Rheum Dis 49(9):682–684PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Szodoray P, Horvath IF, Papp G, Barath S, Gyimesi E, Csathy L, Kappelmayer J, Sipka S, Duttaroy AK, Nakken B et al (2010) The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren’s syndrome. Rheumatology (Oxford) 49(2):211–217CrossRef Szodoray P, Horvath IF, Papp G, Barath S, Gyimesi E, Csathy L, Kappelmayer J, Sipka S, Duttaroy AK, Nakken B et al (2010) The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren’s syndrome. Rheumatology (Oxford) 49(2):211–217CrossRef
7.
Zurück zum Zitat Baldini C, Pepe P, Luciano N, Ferro F, Talarico R, Grossi S, Tavoni A, Bombardieri S (2012) A clinical prediction rule for lymphoma development in primary Sjogren’s syndrome. J Rheumatol 39(4):804–808PubMedCrossRef Baldini C, Pepe P, Luciano N, Ferro F, Talarico R, Grossi S, Tavoni A, Bombardieri S (2012) A clinical prediction rule for lymphoma development in primary Sjogren’s syndrome. J Rheumatol 39(4):804–808PubMedCrossRef
8.
Zurück zum Zitat Voulgarelis M, Tzioufas AG, Moutsopoulos HM (2008) Mortality in Sjogren’s syndrome. Clin Exp Rheumatol 26(5 Suppl 51):S66–S71PubMed Voulgarelis M, Tzioufas AG, Moutsopoulos HM (2008) Mortality in Sjogren’s syndrome. Clin Exp Rheumatol 26(5 Suppl 51):S66–S71PubMed
9.
Zurück zum Zitat Tzioufas AG, Voulgarelis M (2007) Update on Sjogren’s syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 21(6):989–1010PubMedCrossRef Tzioufas AG, Voulgarelis M (2007) Update on Sjogren’s syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 21(6):989–1010PubMedCrossRef
10.
Zurück zum Zitat Baldini C, Giusti L, Bazzichi L, Lucacchini A, Bombardieri S (2008) Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjogren’s syndrome? Autoimmun Rev 7(3):185–191PubMedCrossRef Baldini C, Giusti L, Bazzichi L, Lucacchini A, Bombardieri S (2008) Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjogren’s syndrome? Autoimmun Rev 7(3):185–191PubMedCrossRef
11.
Zurück zum Zitat Baldini C, Giusti L, Ciregia F, Da Valle Y, Giacomelli C, Donadio E, Sernissi F, Bazzichi L, Giannaccini G, Bombardieri S et al (2011) Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren’s syndrome from secondary Sjogren’s syndrome and other sicca syndromes. Arthr Res Ther 13(6):R194CrossRef Baldini C, Giusti L, Ciregia F, Da Valle Y, Giacomelli C, Donadio E, Sernissi F, Bazzichi L, Giannaccini G, Bombardieri S et al (2011) Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren’s syndrome from secondary Sjogren’s syndrome and other sicca syndromes. Arthr Res Ther 13(6):R194CrossRef
12.
Zurück zum Zitat Baldini C, Talarico R, Tzioufas AG, Bombardieri S (2012) Classification criteria for Sjogren’s syndrome: a critical review. J Autoimmun 39(1–2):9–14PubMedCrossRef Baldini C, Talarico R, Tzioufas AG, Bombardieri S (2012) Classification criteria for Sjogren’s syndrome: a critical review. J Autoimmun 39(1–2):9–14PubMedCrossRef
13.
Zurück zum Zitat Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, Soto MJ, Akasbi M, Diaz C, Sentis J et al (2010) Sjogren syndrome or sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 38(2–3):178–185PubMedCrossRef Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, Soto MJ, Akasbi M, Diaz C, Sentis J et al (2010) Sjogren syndrome or sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 38(2–3):178–185PubMedCrossRef
14.
Zurück zum Zitat Giusti L, Baldini C, Bazzichi L, Bombardieri S, Lucacchini A (2007) Proteomic diagnosis of Sjogren’s syndrome. Exp Rev Proteomics 4(6):757–767CrossRef Giusti L, Baldini C, Bazzichi L, Bombardieri S, Lucacchini A (2007) Proteomic diagnosis of Sjogren’s syndrome. Exp Rev Proteomics 4(6):757–767CrossRef
15.
Zurück zum Zitat Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P (2006) Skin involvement and outcome measures in systemic autoimmune diseases. Clin Exp Rheumatol 24(1 Suppl 40):S52–S59PubMed Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P (2006) Skin involvement and outcome measures in systemic autoimmune diseases. Clin Exp Rheumatol 24(1 Suppl 40):S52–S59PubMed
16.
Zurück zum Zitat Agmon-Levin N, Kivity S, Tzioufas AG, Lopez Hoyos M, Rozman B, Efes I, Shapira Y, Shamis A, Amital H, Youinou P (2012) Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren’s syndrome. J Autoimmun 39(3):234–239PubMedCrossRef Agmon-Levin N, Kivity S, Tzioufas AG, Lopez Hoyos M, Rozman B, Efes I, Shapira Y, Shamis A, Amital H, Youinou P (2012) Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren’s syndrome. J Autoimmun 39(3):234–239PubMedCrossRef
17.
Zurück zum Zitat Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2012) Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 97(4):1153–1158PubMedCrossRef Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2012) Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 97(4):1153–1158PubMedCrossRef
18.
Zurück zum Zitat Bang B, Asmussen K, Sorensen OH, Oxholm P (1999) Reduced 25-hydroxyvitamin D levels in primary Sjogren’s syndrome. Correlations to disease manifestations. Scand J Rheumatol 28(3):180–183PubMedCrossRef Bang B, Asmussen K, Sorensen OH, Oxholm P (1999) Reduced 25-hydroxyvitamin D levels in primary Sjogren’s syndrome. Correlations to disease manifestations. Scand J Rheumatol 28(3):180–183PubMedCrossRef
19.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558PubMedCentralPubMedCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C (2010) EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 69(6):1103–1109PubMedCentralPubMedCrossRef Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C (2010) EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 69(6):1103–1109PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Adami S, Romagnoli E, Carnevale V, Scillitani A, Giusti A, Rossini M, Gatti D, Nuti R, Minisola S (2011) Guidelines on prevention and treatment of vitamin D deficiency. Reumatismo 63(3):129–147PubMedCrossRef Adami S, Romagnoli E, Carnevale V, Scillitani A, Giusti A, Rossini M, Gatti D, Nuti R, Minisola S (2011) Guidelines on prevention and treatment of vitamin D deficiency. Reumatismo 63(3):129–147PubMedCrossRef
22.
Zurück zum Zitat Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2):79–84PubMedCrossRef Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2):79–84PubMedCrossRef
23.
Zurück zum Zitat Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S (1999) Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nut 81(2):133–137 Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S (1999) Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nut 81(2):133–137
24.
Zurück zum Zitat Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 14(7):577–582PubMedCrossRef Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 14(7):577–582PubMedCrossRef
25.
Zurück zum Zitat Rossini M, D’Avola G, Muratore M, Malavolta N, Silveri F, Bianchi G, Frediani B, Minisola G, Sorgi ML, Varenna M et al (2013) Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. Reumatismo 65(3):113–120PubMedCrossRef Rossini M, D’Avola G, Muratore M, Malavolta N, Silveri F, Bianchi G, Frediani B, Minisola G, Sorgi ML, Varenna M et al (2013) Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. Reumatismo 65(3):113–120PubMedCrossRef
26.
Zurück zum Zitat Antico A, Tampoia M, Tozzoli R, Bizzaro N (2012) Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 12(2):127–136 Antico A, Tampoia M, Tozzoli R, Bizzaro N (2012) Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 12(2):127–136
27.
Zurück zum Zitat Kriegel MA, Manson JE (2011) Costenbader KH Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum 40(6):512–531PubMedCentralPubMedCrossRef Kriegel MA, Manson JE (2011) Costenbader KH Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum 40(6):512–531PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, Zabek J, Kontny E, McCauliffe D, Wozniacka A (2012) Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 21(5):477–484PubMedCrossRef Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, Zabek J, Kontny E, McCauliffe D, Wozniacka A (2012) Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 21(5):477–484PubMedCrossRef
Metadaten
Titel
Vitamin D in “early” primary Sjögren’s syndrome: does it play a role in influencing disease phenotypes?
verfasst von
Chiara Baldini
Andrea Delle Sedie
Nicoletta Luciano
Pasquale Pepe
Francesco Ferro
Rosaria Talarico
Chiara Tani
Marta Mosca
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 8/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2872-3

Weitere Artikel der Ausgabe 8/2014

Rheumatology International 8/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.